RenovoRx Appoints Experienced Public Company Executive Mark Voll as Chief Financial Officer Life Science Investing
Sensus Healthcare to Report Fourth Quarter and Full Year 2025 Financial Results and Hold Business Update Conference Call on February 12, 2026 Life Science Investing
PRO FAMILIA and Profound Medical Celebrate 500 Sonalleve® Procedures, Expanding Access to Incision-Free Care for Women's Health Life Science Investing
Quantum-Si Announces the Release of Two New Manuscripts Demonstrating the Value of Single-Molecule Protein Sequencing in Clinical Proteomics and Pathogen & Toxin Detection Life Science Investing
Rain Enhancement Technologies Expands Research into Air Quality and Smog Mitigation Life Science Investing
Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026 Life Science Investing
Exicure Announces Publication in Annals of Hematology Highlighting Rapid Stem Cell Mobilization with Burixafor in Patients with Multiple Myeloma and Lymphoma Undergoing Transplant Life Science Investing
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2025 Life Science Investing
Ciena Set to Join S&P 500; Arrowhead Pharmaceuticals to Join S&P MidCap 400; ADT and OneSpaWorld Holdings to Join S&P SmallCap 600 Life Science Investing
Ciena Set to Join S&P 500; Arrowhead Pharmaceuticals to Join S&P MidCap 400; ADT and OneSpaWorld Holdings to Join S&P SmallCap 600 Life Science Investing
Veracyte to Release Fourth Quarter and Full-Year 2025 Financial Results on February 25, 2026 Life Science Investing
